LRMR
#3356
Larimar Therapeutics, Inc. - Common Stock
2.5 3 USD
-0.05%
Market Price
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
Годовой диапазон
Дневное изменение
-5.24%
Месячное изменение
-34.11%
6-месячное изменение
-48.47%
Годовое изменение
-39.33%
Предыдущее закрытие
2.6 7
Open
2.6 6
Low
2.5 3
High
2.6 9
Financials
2021
Current report, 20 May 2021
Larimar Therapeutics, Inc. current report, 20 May 2021
8-K
Current report, 18 May 2021
Larimar Therapeutics, Inc. current report, 18 May 2021
8-K
Current report, 12 May 2021
Larimar Therapeutics, Inc. current report, 12 May 2021
8-K
Current report, 10 May 2021
Larimar Therapeutics, Inc. current report, 10 May 2021
8-K
Quarterly report, Q1 FY2021
Larimar Therapeutics, Inc. quarterly report, Q1 FY2021
10-Q
Current report, 04 Mar 2021
Larimar Therapeutics, Inc. current report, 04 March 2021
8-K
2020
Annual report, FY2020
Larimar Therapeutics, Inc. annual report, FY2020
10-K
Current report, 08 Dec 2020
Larimar Therapeutics, Inc. current report, 08 December 2020
8-K
Current report, 10 Nov 2020
Larimar Therapeutics, Inc. current report, 10 November 2020
8-K
Current report, 27 Oct 2020
Larimar Therapeutics, Inc. current report, 27 October 2020
8-K